Literature DB >> 9341931

Microglial activation in early stages of amyloid beta protein deposition.

A Sasaki1, H Yamaguchi, A Ogawa, S Sugihara, Y Nakazato.   

Abstract

The present study was undertaken to investigate the relationship of microglial activation to amyloid beta protein (A beta) deposition, particularly at the early stage. Using single and double immunostaining methods with a panel of microglia markers and antibodies against A beta and amyloid beta protein precursor (APP), we examined the cerebrum and cerebella of both Alzheimer's disease (AD) and non-demented subjects obtained at autopsy. In nondemented, middle-aged subjects that had small amounts of cerebral A beta deposits, approximately 70% of the diffuse plaques contained ramified microglia. However, no evidence of microglial activation was found in diffuse plaques in any of the non-demented subjects. Dual immunostaining of sections of cerebral cortex using antibodies against A beta and major histocompatibility complex class II antigen showed that in AD subjects, approximately 20% of total diffuse plaques contained a few, activated microglia. Most of these plaques were defined as a transitional from between diffuse and primitive plaques. Both primitive and classic plaques in the cerebral cortex of AD subjects consistently contained clusters of activated microglia. Subpial A beta deposits without neuritic changes lacked microglial activation. In the cerebellum, all of the diffuse plaques lacked microglial activation, and activated microglia in the compact plaques were not as hypertrophic as those in cerebral primitive/classic plaques. Our findings indicate that microglial reactions are absent in the early stages of A beta deposition, and it occurs during the transition from diffuse to primitive plaques, when amounts of A beta deposits and the degree of neuritic changes increase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341931     DOI: 10.1007/s004010050713

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  39 in total

1.  Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism.

Authors:  Gunjan Dhawan; Angela M Floden; Colin K Combs
Journal:  Neurobiol Aging       Date:  2011-12-01       Impact factor: 4.673

Review 2.  The executioners sing a new song: killer caspases activate microglia.

Authors:  J L Venero; M A Burguillos; P Brundin; B Joseph
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 3.  Inflammation and microglia actions in Alzheimer's disease.

Authors:  Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-11       Impact factor: 4.147

4.  Altered microglial copper homeostasis in a mouse model of Alzheimer's disease.

Authors:  Zhiqiang Zheng; Carine White; Jaekwon Lee; Troy S Peterson; Ashley I Bush; Grace Y Sun; Gary A Weisman; Michael J Petris
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

5.  Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.

Authors:  Jeannie-Marie S Leoutsakos; Bengt O Muthen; John C S Breitner; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2011-05-10       Impact factor: 3.485

6.  RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.

Authors:  Anne C Solga; Winnie W Pong; Jason Walker; Todd Wylie; Vincent Magrini; Anthony J Apicelli; Malachi Griffith; Obi L Griffith; Shinichi Kohsaka; Gregory F Wu; David L Brody; Elaine R Mardis; David H Gutmann
Journal:  Glia       Date:  2014-09-24       Impact factor: 7.452

7.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

8.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Authors:  Wolfgang J Streit; Heiko Braak; Qing-Shan Xue; Ingo Bechmann
Journal:  Acta Neuropathol       Date:  2009-06-10       Impact factor: 17.088

Review 9.  Brain extracellular matrix in neurodegeneration.

Authors:  Dafna Bonneh-Barkay; Clayton A Wiley
Journal:  Brain Pathol       Date:  2008-07-25       Impact factor: 6.508

10.  Effects of chronic low dose rotenone treatment on human microglial cells.

Authors:  Shamim B Shaikh; Louise Fb Nicholson
Journal:  Mol Neurodegener       Date:  2009-12-31       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.